Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-30 · accession 0000874015-24-000218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-04 | 2024-08-30 | IONS | Monia Brett P | CEO, Dir | J - Other | $38.64 | +140 | 174.0K | +0.1% | +$5,410 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | J | A | 140 | $38.64 | 174,023 | D | — | — | (F1) Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 30, 2024. These shares may not be sold until February 28, 2025. |